ArticleMolecular carcinogenesis2022

Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers.

Elizabeth Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.